<DOC>
	<DOC>NCT01069783</DOC>
	<brief_summary>The purpose of this trial is to determine the efficacy and safety of A3309 administered to patients with dyslipidemia (high cholesterol levels).</brief_summary>
	<brief_title>Study of A3309 in Patients With Dyslipidemia</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>Patients meet protocol specified criteria for dyslipidemia and has successfully completed study requirements with no clinically relevant findings Medical history or medical condition that would not make the patient a good candidate for the study or would limit the patientÂ´s capability to complete the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>dyslipidemia</keyword>
	<keyword>cholesterol</keyword>
	<keyword>LDL</keyword>
</DOC>